Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:52:57.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide NIH announcement about the terminology transition was added, and the site revision changed from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    1%
    Check dated 2026-10-20T23:52:26.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:17.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A 403 Forbidden error page was added, showing a 403 header and a Home link, indicating the study record cannot be loaded due to access restrictions.
    Difference
    0.5%
    Check dated 2026-09-30T01:06:20.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error. The previously visible study record for NCT01441947 is no longer accessible on this ClinicalTrials.gov page.
    Difference
    19%
    Check dated 2026-09-23T00:58:18.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page displays Revision: v3.7.0 instead of v3.6.6, indicating a minor update to the page template or content management system. This change does not alter the study details or results on the page.
    Difference
    0.1%
    Check dated 2026-09-16T00:10:46.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.